Great Lakes Advisors, LLC

SEC CIK: 0001078013
Latest filing: Aug 10, 2026

SEC filings (opens in a new tab)

EGRX holding history

Eagle Pharmaceuticals, Inc. in every 13F filed by Great Lakes Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EGRX overview All 13F holders of EGRX Full Q2 2026 holdings

Shares (Q3 2024): 0; Sold out in Q3 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2024

Holdings of EGRX by Great Lakes Advisors, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2024	0	$0	0.0%	−23,622−100.0%	Sold out	Holders
Q2 2024	23,622	$132.3K	<0.1%	+12,275+108.2%	Added	Holders
Q1 2024	11,347	$59.5K	<0.1%	+11,347	New	Holders